The European Symposium on Pediatric Cochlear Implantation (ESPCI 2025) will be held in HCC (Hannover Congress Centrum), Hannover, Germany, June 11 – June 14, 2025.
The ESPCI 2025 wants to promote knowledge and skills on paediatric cochlear implantation through the organisation in Europe of a biennial symposium. This symposium aims at improving cochlear implant access, delivery, services and outcomes for children.
ESPCI will be attended by: Otorhinolaryngologists, ENT-surgeons, Audiologists, CI Clinical scientists, Speech- and Language therapists, Psychologists, Teachers for the deaf and residents in training for one of these specialisms.
This time, Nurotron as one of the biggest sponsor of ESPCI 2025, what will Nurotron bring to you? Welcome to our Symposiums:
13:00~14:00, 11th June, 2025, Kuppelsaal
17:15~18:00, 12th June, 2025, Kuppelsaal
Founded in 2006, headquarter in Hangzhou, China and R&D center in Califonia U.S., dedicated to the rehabilitation of people with disabilities. As a trusted CI company, Nurotron aims to improve the quality of life for individuals with hearing loss through innovations in electrode channels, sound processing, etc.
Nurotron manufactures neural electrical stimulation therapy and rehabilitation products including:
- HEARING RESTORATION: Cochlear Implant Series (Implant and Speech Processor)
- VISION RESTORATION: Artificial Retina Implantation System(Implant and Implant External Unit)
- TREATMENT OF UROLOGICAL DISORDERS: Intravesical Electrical Stimulation System, Transcutaneous Tibial Nerve Stimulation System, Sacral Nerve Stimulation System
- TREATMENT OF NEUROLOGICAL DISORDERS: Deep Brain Stimulation System
Due to our commitment to innovation and quality, we supply CI products to more than 20,000 Nurotron users worldwide. Our success is built on several key strengths:
A 10000-square-meter production area
Over 400 dedicated experts
Advanced production facilities
A strict quality control system
Come to visit us, see you at ESPCI 2025!
*Under registration and in preparation for CE conformity assessment.
